
PetMed Express, Inc. (NASDAQ:PETS) Q4 Earnings: Revenue Declines Amidst Improved Loss Per Share
- PetMed Express's Q4 loss per share of -$0.19, while missing analyst estimates, showed significant year-over-year improvement in its latest financial report.
- Quarterly revenue for the online pet pharmacy reached $42.82 million, marking a 15.6% decrease, primarily due to reduced sales of prescription pet medications.
- The company's financial health indicators include a negative price-to-earnings (P/E) ratio of -0.78, a price-to-sales ratio of 0.25, a very low debt-to-equity ratio of 0.02, but a current ratio of 0.84.
PetMed Express, Inc. (NASDAQ:PETS), operating as an online pet pharmacy, is the parent company of PetCareRx. The company provides prescription and non-prescription pet medications, along with other health and wellness products for dogs, cats, and horses, directly to consumers across the United States.
On June 2, 2026, PetMed Express announced a fourth-quarter loss per share of -$0.19. This figure narrowly missed the consensus analyst estimate of -$0.18 per share, as highlighted by Zacks. However, this loss shows a significant improvement from the -$0.56 loss per share reported in the same quarter of the previous year.
The company's revenue for the quarter was $42.82 million. As reported by GlobeNewswire, this represents a 15.6% decrease from the $50.80 million recorded in the prior-year period. This decline in sales was primarily caused by a reduction in the sales of prescription medications for pets.
Based on recent data, PetMed Express has a negative price-to-earnings (P/E) ratio of -0.78. A negative P/E ratio means the company has had negative earnings, or has not been profitable, over the last year. The company's price-to-sales ratio, which compares its stock price to its revenues, is 0.25.
From its balance sheet, the company maintains a very low debt-to-equity ratio of 0.02, indicating it carries little debt relative to its shareholder equity. However, its current ratio is 0.84. A current ratio below 1.0 suggests that a company's short-term debts are greater than its short-term assets.


